Scientific Program

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA27 - Novel Drugs and PDX Models

    • Type: Mini Oral Abstract Session
    • Track: Targeted Therapy
  • +

    MS28 - IO Combinations in Advanced NSCLC

    • Type: Mini Symposium
    • Track: Immunooncology
    • +

      MS28.01 - Understanding the Rationale for Combining IO Agents

      13:30 - 13:45  |  Presenting Author(s): Edward B Garon

      • Abstract

      Abstract not provided

    • +

      MS28.02 - Combination IO+IO

      13:45 - 14:00  |  Presenting Author(s): Myung-Ju Ahn

      • Abstract

      Abstract not provided

    • +

      MS28.03 - Combinatorial IO + Chemo

      14:00 - 14:15  |  Presenting Author(s): Rosalyn Juergens

      • Abstract

      Abstract not provided

    • +

      MS28.04 - Combination with Targeted Therapies

      14:15 - 14:30  |  Presenting Author(s): Ross Soo

      • Abstract

      Abstract not provided

    • +

      MS28.05 - Combining IO with Radiation

      14:30 - 14:45  |  Presenting Author(s): Corinne Faivre-Finn

      • Abstract

      Abstract not provided

    • +

      MS28.06 - Q&A

      14:45 - 15:00

      • Abstract

      Abstract not provided

  • +

    MS29 - Selection into Screening Programs: Interplay of Risk Algorithms, Genetic Markers and Biomarkers

    • Type: Mini Symposium
    • Track: Screening and Early Detection
  • +

    MS30 - Modern Day RT in LA NSCLC: Where Is the Evidence?

    • Type: Mini Symposium
    • Track: Treatment of Locoregional Disease - NSCLC
    • +

      MS30.01 - Introduction with Poll Questions

      13:30 - 13:35  |  Presenting Author(s): Fiona Hegi-Johnson, Yuko Nakayama

      • Abstract

      Abstract not provided

    • +

      MS30.01 - Overview of RT Technology in LA NSCLC (IMRT, VMAT, IGRT)

      13:35 - 13:50  |  Presenting Author(s): Gerard G Hanna

      • Abstract

      Abstract not provided

    • +

      MS30.02 - What Evidence Is Available to Support RT Technology in LA NSCLC (including Protons)?

      13:50 - 14:05  |  Presenting Author(s): Yong Chan Ahn

      • Abstract

      Abstract not provided

    • +

      MS30.03 - What Evidence Is Available to Support RT Treatment Intensification in LA NSCLC?

      14:05 - 14:20  |  Presenting Author(s): Jeffrey Bradley

      • Abstract

      Abstract not provided

    • +

      MS30.04 - Perspective

      14:20 - 14:35  |  Presenting Author(s): Maria Werner-Wasik

      • Abstract

      Abstract not provided

    • +

      MS30.05 - Nutritional Management During Radical Radiotherapy

      14:35 - 14:50  |  Presenting Author(s): Rhys White

      • Abstract

      Abstract not provided

    • +

      MS30.06 - Q&A with Poll Questions

      14:50 - 15:00

      • Abstract

      Abstract not provided

  • +

    MS31 - Clinical Science in Mesothelioma

    • Type: Mini Symposium
    • Track: Mesothelioma
    • +

      MS31.01 - Mechanisms and Targets for BAP1 Activity

      13:30 - 13:45  |  Presenting Author(s): Michele Carbone

      • Abstract

      Abstract not provided

    • +

      MS31.02 - Clinical Implementation of BAP1 Inhibitors

      13:45 - 14:00  |  Presenting Author(s): Paul Baas  |  Author(s): Laurel Schunselaar

      • Abstract

      Abstract not provided

    • +

      MS31.03 - Targeting the Hippo Pathway

      14:00 - 14:15  |  Presenting Author(s): David Mark Jablons  |  Author(s): Gavitt A. Woodard

      • Abstract

      Abstract not provided

    • +

      MS31.04 - CAR-T and ADC's in MPM

      14:15 - 14:30  |  Presenting Author(s): Prasad S. Adusumilli

      • Abstract

      Abstract not provided

    • +

      MS31.05 - Vaccination and Antibody-Based Therapy in Mesothelioma

      14:30 - 14:45  |  Presenting Author(s): Joachim G.J.V. Aerts

      • Abstract

      Abstract not provided

    • +

      MS31.06 - Q&A

      14:45 - 15:00

      • Abstract

      Abstract not provided

  • +

    MS32 - SCLC - From Benchside to Bedside - Clinical Science Session

    • Type: Mini Symposium
    • Track: Small Cell Lung Cancer/NET
  • +

    PL04 - Take Action - Key Messages from WCLC 2018 and Goals for 2019

    • Type: Plenary Session
    • Track:
    • +

      PL04.01 - Immunotherapy

      15:15 - 15:25  |  Presenting Author(s): David R. Gandara

      • Abstract

      Abstract not provided

    • +

      PL04.02 - Biomarkers

      15:25 - 15:35  |  Presenting Author(s): Ming Sound Tsao

      • Abstract

      Abstract not provided

    • +

      PL04.03 - Surgery

      15:35 - 15:45  |  Presenting Author(s): Ramon Rami-Porta

      • Abstract

      Abstract not provided

    • +

      PL04.04 - Radiation Oncology

      15:45 - 15:55  |  Presenting Author(s): Jose Belderbos

      • Abstract

      Abstract not provided

    • +

      PL04.05 - Clinical Research in Latin America

      15:55 - 16:05  |  Presenting Author(s): Clarissa Mathias

      • Abstract

      Abstract not provided

    • +

      PL04.06 - Targeted Therapy

      16:05 - 16:15  |  Presenting Author(s): Michael Boyer

      • Abstract

      Abstract not provided

    • +

      PL04.07 - Discussion and Q&A

      16:15 - 16:25

      • Abstract

      Abstract not provided

    • +

      PL04.08 - Invitation to WCLC 2019 Barcelona, Spain

      16:25 - 16:30

      • Abstract

      Abstract not provided